Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ibuprofen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Motrin 800mg tablets
1001010J0BHADAG
|
Motrin | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Noubid 200mg tablets
1001010J0DLAAAD
|
Noubid | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Numark Ibuprofen Pain Relief 5% gel
1003020P0BQACAC
|
Numark (Topical Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Numark Max Strength Pharmacy Ibuprofen 400mg tablets
1001010J0CDADAE
|
Numark Ibuprofen (Systemic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 200mg caplets
1001010J0B4AEAD
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 200mg liquid capsules
1001010J0B4AIAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 200mg tablets
1001010J0B4ABAD
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 5% gel
1003020P0BLAAAC
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Express Period Pain 200mg capsules
1001010J0B4AWAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Extra Strength 400mg capsules
1001010J0B4ATAU
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen for Children Singles 100mg/5ml susp 5ml strawberry
1001010J0B4ARBM
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Joint & Back Pain Relief 5% gel
1003020P0BLADAC
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Long Lasting 300mg capsules
1001010J0B4AGAB
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Maximum Strength 10% gel
1003020P0BLABAI
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Recovery 200mg orodispersible tablets
1001010J0B4AMBN
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Sinus Pressure & Headache Relief 200mg/30mg tablets
1001010J0B4BABJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Sinus tablets
1001010J0B4ASBJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Orbifen For Children 100mg/5ml oral suspension
1001010J0CRAABH
|
Orbifen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Orbifen For Children 100mg/5ml oral suspension 5ml sachets
1001010J0CRABBM
|
Orbifen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Pacifene 200mg tablets
1001010J0BUAAAD
|
Pacifene | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Paramed Ibuprofen 200mg liquid capsules
1001010J0DFAEAA
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Pedea 10mg/2ml solution for infusion ampoules
0701011F0BBAAAA
|
Pedea | Ibuprofen | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Proflex 5% cream
1003020P0BBAAAA
|
Proflex (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Proflex Pain Relief 5% cream
1003020P0BBABAA
|
Proflex (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Pure Health Junior Ibuprofen 100mg/5ml oral suspension
1001010J0DEAABH
|
Pure Health Ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.